Internal Medicine, Endocrinology, Diabetes, & Metabolism · Roseburg, OR
NPI
1538254941
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2570 NW Edenbower Blvd., Suite 100
Roseburg, OR, 97471
Phone (541) 677-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,592
24 services
Medicare patients, 2024
14
Average age 77
Drug cost, 2024
$1.7M
4,012 prescriptions
Company payments, 2025
$182
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Patrick W Clyde prescribed most often to Medicare patients was Levothyroxine Sodium, with 531 prescriptions and refills. In total Patrick W Clyde wrote 4,012 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 531 | 1,443 | 146 | $6,845 |
| Ozempic Semaglutide | 315 | 454 | 68 | $424K |
| Jardiance Empagliflozin | 206 | 368 | 47 | $205K |
| Metformin Hcl Er Metformin Hcl | 186 | 443 | 62 | $1,793 |
| Methimazole Generic | 172 | 410 | 47 | $1,704 |
| Trulicity Dulaglutide | 145 | 190 | 38 | $179K |
| Semglee (Yfgn) Pen Insulin Glargine-Yfgn | 109 | 231 | 38 | $63K |
| Insulin Aspart Flexpen Insulin Aspart | 92 | 192 | 33 | $20K |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 90 | 168 | 31 | $64K |
| Novolog Flexpen Insulin Aspart | 88 | 158 | 26 | $20K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 83 | 205 | 26 | $51K |
| Metformin Hcl Generic | 82 | 225 | 27 | $815 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 81 | 188 | 24 | $43K |
| Gabapentin Generic | 72 | 166 | 18 | $1,882 |
| Humalog Kwikpen U-100 Insulin Lispro | 69 | 163 | 26 | $18K |
Brand drugs: 2,163 claims; generic drugs: 1,662 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick W Clyde $182 ($182 in general payments such as food, travel and fees) from 5 companies. The largest payer was Tandem Diabetes Care, Inc. with $60.41.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.